FindTrial
Sign In

Influence of treatment modality on the prognosis of patients with nasal cavity and paranasal sinus skull base tumors: a study based on medical records

Influence of treatment methods on the prognosis of patients with nasal cavity, paranasal sinus and skull base tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048214
Enrollment
Unknown
Registered
2021-07-05
Start date
2021-07-05
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignancies of sinonasal tract and anterior skull base

Interventions

Surgery:Nil
Chemotherapy alone:Nil

Sponsors

The First Affiliated Hospital, Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 93 Years

Inclusion criteria

Inclusion criteria: Patients diagnosed with malignant tumors of the nasal cavity and paranasal sinuses in our hospital from January 1, 2000 to December 31, 2018.

Exclusion criteria

Exclusion criteria: 1. Patients who were diagnosed with nasal cavity and sinus malignant tumors in our hospital without any treatment and were discharged from the hospital; 2. Patients who have not completed any follow-up or diagnosed with nasopharyngeal carcinoma or lymphoma.

Design outcomes

Primary

MeasureTime frame
Overall survival;—

Countries

China

Contacts

Public ContactChen Mengyu

The First Affiliated Hospital, Sun Yat-Sen University

mumuaaaaa@126.com+86 18926267438

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026